Use of US Food and Drug Administration Expedited Drug Development and Review Programs by Orphan and Nonorphan Novel Drugs Approved From 2008 to 2021

por Monge, Andrea N., Sigelman, Daniel W., Temple, Robert J., Chahal, Harinder Singh
Publicado 2022